White Papers

  1. Trust In AI Agents Has To Be Earned Continuously, Not Just Once 9/7/2026

    This white paper lays out how ongoing performance monitoring, version control, and audit-ready traceability keep agentic AI trustworthy in a regulated environment.

  2. A Practical Guide To Harnessing The Value Of APAC For Global Trial Success 8/21/2026

    As Phase III costs and complexity rise, APAC offers faster enrollment, lower costs, and market access advantages, but capturing that value requires early planning and in-region expertise.

  3. Five Integration Pillars To Redefine Frontline Patient Engagement And Safety Operations 8/20/2026

    Siloed medical information, patient support, product quality, and pharmacovigilance functions, alongside increasing biopharmaceutical complexity, require a unified operating model to meet modern demand.

  4. Navigating Large-Volume Subcutaneous Biologic Injections 8/12/2026

    Large-volume subcutaneous delivery is bringing biologic treatments closer to patients. Learn how advances in dosing and device technology are shaping care.

  5. Flying On Two Wings: Balancing Local Agility And Global Quality In China 8/12/2026

    As China expands its role in drug development, injectable therapy programs face new demands. Learn how manufacturers are scaling quality, devices, and production for global success.

  6. Matching Pharmacovigilance Methodology To Organizational Scale 8/12/2026

    One-size-fits-all doesn't work for safety signal detection. Discover a scalable framework that keeps expert judgment at the center — no matter how large your portfolio grows.

  7. Flexibility In Drug Development: From Tactical Response To Strategic Discipline 8/10/2026

    Historically managed through late-stage adjustments, operational adaptability has become a strategic imperative to prevent programs from stalling under real-world pressures.

  8. Collaborate To Improve The Patient Experience 8/8/2026

    Fragmented trial operations trigger costly enrollment delays. Discover how operational alignment among sponsors, CROs, and site networks drives patient retention and study success.

  9. Redefining Vaccine Trial Recruitment 8/8/2026

    Modern vaccine trials demand flexible, transparent recruitment workflows. Discover strategies to overcome enrollment delays and build representative, diverse study cohorts.

  10. Overcoming Obesity Trial's Patient Engagement And Retention Challenges 8/8/2026

    Extended obesity trials often face high dropout rates due to fatigue and strict protocols. Learn how personalized engagement and strong care relationships improve participant retention.